Black Seed

1. What conditions has Black Seed been studied for?

• Glycemic control / diabetes-related markers: fasting glucose and HbA1c were assessed in a large systematic review/meta-analysis of trials.

• Dyslipidemia (abnormal blood lipids): total cholesterol, LDL, VLDL, triglycerides were evaluated in a meta-analysis and in a randomized double-blind trial of powdered seeds.

• Hypertension (high blood pressure): evaluated in a meta-analysis of adult supplementation trials.

• Inflammation and oxidative stress biomarkers: CRP, TNF-α, total antioxidant capacity (TAC), malondialdehyde (MDA) were analyzed in a meta-analysis.

• Endothelial function / vascular inflammation markers: ICAM and VCAM were evaluated in a systematic review/meta-analysis (3 RCTs, 146 participants) in people with CVD or CVD risk.

• Cognition in healthy older adults: memory, attention, and cognition were tested in a 9-week placebo-controlled trial (500 mg twice daily).

• Central obesity / metabolic markers in men: body weight, waist circumference, blood pressure, free testosterone, adiponectin, hs-CRP, glucose and lipids were studied in a placebo-controlled trial.

• Allergic diseases: allergic rhinitis (including as an adjunct to allergen-specific immunotherapy), and broader allergic conditions (rhinitis, asthma, atopic eczema) were studied using seeds or oil.

2. Does it work in treating those conditions? Summarize the evidence.

• Blood sugar control: A meta-analysis of 50 trials found significant reductions in fasting glucose (WMD about −15.18) and HbA1c (WMD about −0.45). This supports a modest improvement in glycemic control on average, though individual trial quality and heterogeneity are not detailed in the study.

• Lipids: The same meta-analysis reported significant reductions in total cholesterol (WMD about −16.80), triglycerides (−15.73), LDL (−18.45), and VLDL (−3.72). A separate randomized double-blind trial of powdered seed capsules reported “favorable impact” on multiple metabolic variables but not statistically significant results, largely attributed to small sample size and high dropout.

• Blood pressure: A meta-analysis (to Aug 2022) found statistically significant reductions in systolic BP (WMD −3.06 mmHg) and diastolic BP (WMD −2.69 mmHg), but with very high heterogeneity (I² ~85–97%), meaning effects likely vary substantially across studies and populations.

• Inflammation/oxidative stress biomarkers: In the 50-trial meta-analysis, effects were not significant for CRP, TNF-α, TAC, or MDA (confidence intervals crossed no effect). This suggests benefits on glucose/lipids may not consistently translate into measurable changes in these biomarkers (at least across included trials).

• Endothelial markers (ICAM/VCAM): A 2023 systematic review/meta-analysis of 3 RCTs (146 participants) found no significant effect on ICAM or VCAM, with severe heterogeneity. Evidence is currently limited and inconclusive for endothelial function improvement.

• Cognition in healthy elderly: A 9-week placebo-controlled trial (500 mg twice daily) reported statistically significant improvements across multiple neuropsychological tests (memory, attention, processing speed/executive tasks). This is promising but based on a small sample (n=40) and short duration; it does not establish prevention or treatment of Alzheimer’s disease.

• Central obesity/metabolic restoration in obese men: A placebo-controlled trial reported a “very significant” reduction in body weight and waist circumference, while many lab markers (free testosterone, glucose, triglycerides, hs-CRP, adiponectin) changed in favorable directions but were often not statistically significant. This suggests possible benefit for anthropometrics, but the evidence is limited by sample size and unclear dosing details in the study.

• Allergic rhinitis and other allergic diseases: In allergic rhinitis patients receiving immunotherapy, adding N. sativa seeds (2 g/day) for 30 days significantly increased certain immune function measures (PMN phagocytic/killing activity; CD8 counts) versus immunotherapy alone. A separate summary of four studies (152 patients) using black seed oil (40–80 mg/kg/day) reported improved subjective symptom scores across allergic rhinitis/asthma/atopic eczema. Another double-blind trial in allergic rhinitis (66 patients) evaluated symptom severity over 30 days with N. sativa oil; the study is truncated, so outcomes cannot be fully confirmed from the provided text.

3. What health benefits does it have?

• Improved lipid profile (average effects across trials): reductions in total cholesterol, LDL, VLDL, and triglycerides were significant in the 50-trial meta-analysis.

• Improved glycemic markers: significant reductions in fasting glucose and HbA1c in the same meta-analysis suggest potential support for metabolic health.

• Small reductions in blood pressure: meta-analysis evidence suggests modest average decreases (~3 mmHg systolic, ~2–3 mmHg diastolic), though results vary widely between studies.

• Possible cognitive support in healthy older adults: a small 9-week RCT reported improvements in memory, attention, and cognition test performance.

• Weight and waist circumference reduction (limited evidence): one placebo-controlled trial in centrally obese men reported significant reductions in weight and waist circumference.

• Adjunct support in allergic disease: studies reported improvements in subjective allergy symptoms (rhinitis/asthma/eczema) and some immune function measures when used alongside immunotherapy in allergic rhinitis.

Important limitation across benefits: several areas show high heterogeneity, small sample sizes, short durations, and/or reliance on subjective symptom scoring, so certainty varies by outcome.

4. Does it have any downsides or side effects?

• Short-term safety signals in the provided trials were generally reassuring: the 9-week elderly cognition trial reported no statistically significant changes in measured cardiac/liver/kidney biochemical markers during the study period.

• Central obesity trial: reported “no side effects” detected in the treatment group (per abstract), but details on adverse event monitoring are limited.

• Evidence gaps: the studies do not provide robust adverse event rates across large populations, long-term safety, pregnancy safety, or interactions with common medications (e.g., antihypertensives, glucose-lowering drugs, anticoagulants). Given the observed average reductions in glucose and blood pressure, a plausible concern (not proven in these studies) is additive effects when combined with medications, warranting monitoring.

• Trial limitations affecting safety interpretation: some studies had small sample sizes and high dropout (e.g., the Karachi trial), which can reduce the ability to detect uncommon side effects.

5. Is it beneficial or harmful for any genetic variations (pharmacogenomics)?

The studies reviewed here do not report pharmacogenomic analyses or outcomes stratified by genetic variants (e.g., drug-metabolizing enzymes, transporter genes, or disease-risk genotypes). Therefore:

• No evidence from these studies that Nigella sativa is specifically beneficial or harmful for particular genetic variations.

• Key limitation: without genotype-stratified trials or mechanistic human studies linking black seed constituents to specific genetic pathways, pharmacogenomic conclusions cannot be made from the supplied evidence.

Black Seed Oil

Across the studies reviewed here, research on black seed oil (BSO; Nigella sativa) is concentrated in three main areas: (1) mechanistic and analytical studies of its key bioactive thymoquinone (TQ), particularly antioxidant and redox behavior (e.g., superoxide scavenging measured electrochemically and supported by computational chemistry); (2) formulation and drug-delivery engineering to overcome TQ/BSO biopharmaceutical limitations (poor aqueous solubility, limited permeability, and the need for controlled release), including nanoemulsion hydrogels for topical delivery, alginate bead systems for gastrointestinal controlled release, and self-nanoemulsifying drug delivery systems (SNEDDS) that also enhance dissolution of co-loaded compounds such as curcumin and piperine; and (3) preclinical bioactivity studies spanning antimicrobial/anti-inflammatory effects (including modified “ozonized” BSO) and anticancer mechanisms (e.g., TQ-induced apoptosis in bladder cancer cell lines). A smaller portion of the material is review-oriented and hypothesis-generating for complex diseases (e.g., diabetes and COVID-19), emphasizing immunomodulatory and antiviral plausibility.

The strongest evidence in this set supports that TQ and BSO have measurable antioxidant activity under controlled experimental conditions (notably superoxide scavenging for TQ and BSO, with negative findings for thymohydroquinone in the cited assay), and that advanced formulations can reproducibly improve physicochemical performance relevant to delivery (e.g., sub-100 nm droplets, improved solubilization/dissolution, and controlled-release behavior in vitro/ex vivo). There is also consistent preclinical evidence—primarily in vitro—that TQ can exert cytotoxic and pro-apoptotic effects in cancer cell models, and that chemical modification of BSO (ozonation) can alter composition and increase antimicrobial activity against several tested organisms. For COVID-19 and other systemic indications, the studies largely reflect mechanistic rationale and docking/early antiviral observations rather than definitive clinical efficacy.

Key gaps include a need for more rigorous human clinical trials that link standardized BSO/TQ preparations to clinically meaningful outcomes, with appropriate controls, dose–response characterization, and safety monitoring. Additional priorities are harmonization of product chemistry (batch-to-batch variability, quantification of TQ and other constituents, and effects of processing such as ozonation), and translational validation that formulation advances (nanoemulsions, SNEDDS, beads) improve in vivo bioavailability and therapeutic endpoints rather than only in vitro dissolution or release profiles. Finally, many disease claims remain supported mainly by cell-based or computational studies; stronger evidence will require animal and human studies that clarify mechanisms, pharmacokinetics, drug–herb interactions, and long-term safety across target populations.

References

1. Effects of Nigella sativa on glycemic control, lipid profiles, and biomarkers of inflammatory and oxidative stress: A systematic review and meta-analysis of randomized controlled clinical trials
   Jamal Hallajzadeh, Alireza Milajerdi, Moein Mobini, Elaheh Amirani, Susan Azizi (2020)
2. Effectiveness, safety, and tolerability of powdered Nigella sativa (kalonji) seed in capsules on serum lipid levels, blood sugar, blood pressure, and body weight in adults: results of a randomized, double-blind controlled trial
   Waris Qidwai, Hasan Bin Hamza, Riaz Qureshi, Anwar Gilani (2009)
3. Antihypertensive effects of Nigella sativa supplementation: An updated systematic review and meta-analysis of randomized controlled trials
   Zeynab Kavyani, Vali Musazadeh, Ehsan Safaei, Mina Mohammadi Asmaroud, Fatemeh Khashakichafi (2023)
4. Endothelial Function Responses to Nigella sativa (Black Seed) Supplementation: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
   Mahmoud Ali, Mariam Tantawi, Abdallah Hussien Kamel, Zeyad Firas Tameemi, Afnan A Rezk (2024)
5. The effect of Nigella sativa Linn. seed on memory, attention and cognition in healthy human volunteers
   Muhammad Shahdaat Bin Sayeed, Md Asaduzzaman, Helal Morshed, Md Monir Hossain, Mohammad Fahim Kadir (2013)
6. Efficacy of Nigella sativa on serum free testosterone and metabolic disturbances in central obese male
   E A Datau, Wardhana, Eko E Surachmanto, K Pandelaki, J A Langi (2010)
7. Potential adjuvant effects of Nigella sativa seeds to improve specific immunotherapy in allergic rhinitis patients
   Hülya Işik, Adile Cevikbaş, Umran Soyoğul Gürer, Bayram Kiran, Yağiz Uresin (2010)
8. Effect of Nigella sativa (black seed) on subjective feeling in patients with allergic diseases
   Ulrich Kalus, Axel Pruss, Jaromir Bystron, Moric Jurecka, Alice Smekalova (2003)
9. Herbal treatment of allergic rhinitis: the use of Nigella sativa
   Soheila Nikakhlagh, Fakher Rahim, Faezeh Hossein Nejad Aryani, Amir Syahpoush, Mehri Ghafouryan Brougerdnya (2011)
10. Clinical evaluation of Nigella sativa seeds for the treatment of hyperlipidemia: a randomized, placebo controlled clinical trial
    Ali Mohammad Sabzghabaee, Mehrnoush Dianatkhah, Nizal Sarrafzadegan, Sedigheh Asgary, Alireza Ghannadi (2012)
11. The possible prophylactic effect of Nigella sativa seed extract in asthmatic patients
    Mohammad Hossein Boskabady, H Javan, M Sajady, H Rakhshandeh (2007)
12. Antihypertensive effect of Nigella sativa seed extract in patients with mild hypertension
    Farshad Roghani Dehkordi, Amir Farhad Kamkhah (2008)
13. Effects of Nigella sativa on outcome of hepatitis C in Egypt
    Eman Mahmoud Fathy Barakat, Lamia Mohamed El Wakeel, Radwa Samir Hagag (2013)
14. Effectiveness of Nigella sativa oil in the management of rheumatoid arthritis patients: a placebo controlled study
    Tamer A Gheita, Sanaa A Kenawy (2012)
15. Effect of Nigella sativa seeds on the glycemic control of patients with type 2 diabetes mellitus
    Abdullah O Bamosa, Huda Kaatabi, Fatma M Lebdaa, Abdul-Muhssen Al Elq, Ali Al-Sultanb (2010)
16. Nigella sativasupplementation improves cardiometabolic indicators in population with prediabetes and type 2 diabetes mellitus: A systematic review and meta-analysis of randomized controlled trials
    Saeede Saadati, Kaveh Naseri, Omid Asbaghi, Khadijeh Abhari, Pangzhen Zhang (2022)
17. The effect of Nigella sativa (black seed) on biomarkers of inflammation and oxidative stress: an updated systematic review and meta-analysis of randomized controlled trials
    Zeynab Kavyani, Vali Musazadeh, Sahar Golpour-Hamedani, Amir Hossein Moridpour, Mahdi Vajdi (2023)
18. The possible prophylactic effect of Nigella sativa seed aqueous extract on respiratory symptoms and pulmonary function tests on chemical war victims: a randomized, double-blind, placebo-controlled trial
    Mohammad H Boskabady, Javad Farhadi (2008)
19. Effect ofNigella sativaConsumption on Lipid Profile and Glycemic Index in Patients with Metabolic Syndrome: A Systematic Review and Meta-analysis of Randomized Controlled Trials
    Maryam Shabani, Farideh Ghavidel, Arezoo Rajabian, Masoud Homayouni-Tabrizi, Tannaz Jamialahmadi (2025)
20. Effect of Nigella sativa oil on various clinical and biochemical parameters of insulin resistance syndrome
    Ahmad Najmi, Mohammad Nasiruddin, Rahat Ali Khan, Shahzad F Haque (2008)
21. Antioxidant Properties of Thymoquinone, Thymohydroquinone and Black Cumin (
    Raiyan Sakib, Francesco Caruso, Sandjida Aktar, Stuart Belli, Sarjit Kaur, Melissa Hernandez, Miriam Rossi (2023) - Antioxidants (Basel, Switzerland)
22. Thymoquinone Loaded Topical Nanoemulgel for Wound Healing: Formulation Design and In-Vivo Evaluation.
    Mohammed S Algahtani, Mohammad Zaki Ahmad, Ibrahim Ahmed Shaikh, Basel A Abdel-Wahab, Ihab Hamed Nourein, Javed Ahmad (2021) - Molecules (Basel, Switzerland)
23. Encapsulation of Black Seed Oil in Alginate Beads as a pH-Sensitive Carrier for Intestine-Targeted Drug Delivery: In Vitro, In Vivo and Ex Vivo Study.
    Abul Kalam Azad, Sinan Mohammed Abdullah Al-Mahmood, Bappaditya Chatterjee, Wan Mohd Azizi Wan Sulaiman, Tarek Mohamed Elsayed, Abd Almonem Doolaanea (2020) - Pharmaceutics
24. Bioactive Self-Nanoemulsifying Drug Delivery Systems (Bio-SNEDDS) for Combined Oral Delivery of Curcumin and Piperine
    Mohsin Kazi, Ahmad A Shahba, Saad Alrashoud, Majed Alwadei, Abdelrahman Y Sherif (2020)
25. A Narrative Review on Various Oil Extraction Methods, Encapsulation Processes, Fatty Acid Profiles, Oxidative Stability, and Medicinal Properties of Black Seed (
    Muhammad Abdul Rahim, Aurbab Shoukat, Waseem Khalid, Afaf Ejaz, Nizwa Itrat, Iqra Majeed, Hyrije Koraqi, Muhammad Imran, Mahr Un Nisa, Anum Nazir, Wafa S Alansari, Areej A Eskandrani, Ghalia Shamlan, Ammar Al-Farga (2022) - Foods (Basel, Switzerland)
26. Thymoquinone: A Promising Natural Compound with Potential Benefits for COVID-19 Prevention and Cure.
    Osama A Badary, Marwa S Hamza, Rajiv Tikamdas (2021) - Drug design, development and therapy
27. Effect of ozonation on the phytochemicals of black seed oil and its anti-microbial, anti-oxidant, anti-inflammatory, and anti-neoplastic activities in vitro.
    Aisha M H Al-Rajhi, Tarek M Abdelghany, Mohammed S Almuhayawi, Mohammed H Alruhaili, Amna A Saddiq, Afra M Baghdadi, Soad K Al Jaouni, Hibah M Albasri, Moayad S Waznah, Faisal A Alraddadi, Samy Selim (2024) - Scientific reports
28. Thymoquinone induces apoptosis in bladder cancer cell via endoplasmic reticulum stress-dependent mitochondrial pathway.
    Mengzhao Zhang, Hongxia Du, Zhixin Huang, Pu Zhang, Yangyang Yue, Weiyi Wang, Wei Liu, Jin Zeng, Jianbin Ma, Guanqiu Chen, Xinyang Wang, Jinhai Fan (2018) - Chemico-biological interactions
29. Investigations on the shelf life of rainbow trout fillets covered by quinoa biofilms enriched with different essential oils (
    Kübra Güler, Telat Yanık, Gonca Alak (2024) - Food science and technology international = Ciencia y tecnologia de los alimentos internacional
30. The effects of twenty-four nutrients and phytonutrients on immune system function and inflammation: A narrative review.
    Jillian Poles, Elisa Karhu, Megan McGill, H Reginald McDaniel, John E Lewis (2021) - Journal of clinical and translational research
31. In Vitro and In Vivo Preventive Effects of Thymoquinone against Breast Cancer: Role of DNMT1.
    Mohammed Kaleem, Asaad Kayali, Ryan A Sheikh, Abudukadeer Kuerban, Mohammed A Hassan, Naif Abdullah R Almalki, Fahad A Al-Abbasi, Firoz Anwar, Ziad Omran, Mahmoud Alhosin (2024) - Molecules (Basel, Switzerland)
32. Soy protein isolate film activated by black seed oil nanoemulsion as a novel packaging for shelf-life extension of bulk bread.
    Negin Hosseiniyeh, Forogh Mohtarami, Hadi Almasi, Saeedeh Azizi (2024) - Food science & nutrition
33. Antifungal activity of eco-safe nanoemulsions based on
    Mohamed A Mosa, Khamis Youssef, Said F Hamed, Ayat F Hashim (2022) - Frontiers in microbiology
34. Development of a Multifunctional Oral Dosage Form via Integration of Solid Dispersion Technology with a Black Seed Oil-Based Self-Nanoemulsifying Drug Delivery System.
    Abdelrahman Y Sherif, Ahmad Abdul-Wahhab Shahba (2023) - Biomedicines
35. Combined Ramipril and Black Seed Oil Dosage Forms Using Bioactive Self-Nanoemulsifying Drug Delivery Systems (BIO-SNEDDSs).
    Ahmad Abdul-Wahhab Shahba, Abdelrahman Y Sherif, Ehab M Elzayat, Mohsin Kazi (2022) - Pharmaceuticals (Basel, Switzerland)
36. Anti-Aging Effect of Nigella Sativa Fixed Oil on D-Galactose-Induced Aging in Mice.
    Mahdieh Jafari Shahroudi, Soghra Mehri, Hossein Hosseinzadeh (2017) - Journal of pharmacopuncture
37. Thymoquinone enhances cisplatin-response through direct tumor effects in a syngeneic mouse model of ovarian cancer.
    Andrew J Wilson, Jeanette Saskowski, Whitney Barham, Fiona Yull, Dineo Khabele (2015) - Journal of ovarian research
38. Protective effect of some plant oils on diazinon induced hepatorenal toxicity in male rats.
    Atef M Al-Attar, Moustafa H R Elnaggar, Essam A Almalki (2017) - Saudi journal of biological sciences

This article summarizes published research for educational purposes. It is not medical advice. Talk to your doctor before starting, stopping, or changing any supplement or medication.